11, 108
The UK Biobank, an organisation that plans to collect genetic data from half a million volunteers aged 45-69, has launched a draft ethics and governance framework to address concerns such as confidentiality and the use of its data.
Professor John Newton, its chief executive officer, said, "The framework will ensure the interests of the participants are protected."
The framework addresses the issue of consent. Participants in the project will be consenting to "participate in UK Biobank," and this consent will cover any project for which the data is subsequently used. Proposals to use the data will be scrutinised by UK Biobank and subjected to peer review and to ethical review by an NHS multicentre research ethics committee.
Kathryn Godfrey London
The framework can be seen at www.ukbiobank.ac.uk Parathyroid hormone alone is as effective as combination in treating osteoporosis
52
Combining parathyroid hormone with the osteoporosis drug alendronate does not seem to increase bone density any more than parathyroid hormone alone.
"It looks like you don't see the synergism or additive effect that we had hoped to see," said Dennis Black, professor of epidemiology and biostatistics at the University of California, San Francisco, and the study's lead investigator.
The study was published in the online version of the New England Journal of Medicine ahead of schedule to coincide with presentations at a meeting of the American Society for Bone and Mineral Research and appears in the print journal on 25 September (2003; 349:1019-26) .
Scott Gottlieb New York
Cancer rates in Europe are linked to overweight, experts warn
156, 170, 217
Overweight and obesity account for over 50 000 "avoidable" cases of cancer in European Union countries every year, 9000 of which are in the United Kingdom alone.
Speaking at a conference in London on obesity, nutrition, and cancer last week, which was organised by the World Cancer Research Fund and sponsored by the Department of Health, experts warned that the rapidly rising prevalence of obesity is taking a huge toll on global health.
Obesity is thought to increase the overall risk of cancer by 25% in men and 37% in women, and it particularly increases susceptibility to cancers of the reproductive organs, breast, kidneys, gullet, and bowel.
In the United Kingdom, where obesity is estimated to cost around £4bn ($6.6bn; €5.7bn) a year in terms of associated healthcare expenditure and lost productivity, rates are rising faster than anywhere else in Europe, with one in five Britons now overweight or obese.
Countries once acclaimed for their healthy eating-such as Italy, Spain, and Greece-now have some of the highest rates of childhood obesity and overweight in Europe, affecting around one in three children.
Caroline White London
Illinois is to estimate savings from letting its employees import cheap drugs
186, 218, 117
The governor of Illinois has fired the latest salvo at the Bush administration's policy of opposing the importation of cheap drugs from Canada.
Rod Blagojevich has directed state officials to investigate how much money could be saved by allowing thousands of current and retired state employees to import prescription drugs from Canada.
The governor's action is part of an ongoing revolt against the high cost of drugs in the United States, which can be bought from 25% to 80% more cheaply abroad.
In July 2002 the US Senate approved a proposal to permit certain imports from Canada by licensed pharmacists and drug wholesalers (BMJ 2002; 325:183) . Then last July the House of Representatives passed a bill approving imports. But to become law such proposed legislation needs to be approved by both houses and then to be signed by President Bush-and although attempts are being made to reconcile differences in the bills, observers doubt that such approval will be given.
Last March the Food and Drug Administration also threatened to take legal action against drug importers (BMJ 2003: 326:618) .
David Spurgeon Quebec
Australia opts to label drugs developed through stem cell research
186, 214
The Australian government will require that drug manufacturers disclose whether material from bmj.com news roundup This picture of an eye haemorrhage has won the healthcare award in the 2003 Novartis and the Daily Telegraph Visions of Science photographic awards. Taken by medical photographer Joss Dimock, the image shows bleeding from abnormal blood vessel growth in the retina, resulting in an unusually large haemorrhage and temporary blindness in this eye. The optic nerve head can be seen as the pale yellow disc on the left of the picture.
Joss Dimock received her £500 prize, which was sponsored by the BMJ, on Tuesday from Lord May, president of the Royal Society, at the award ceremony held at the Royal Society, in London.
A coloured x ray picture of a fractured tibia and fibula by Dr Mike Hill, a physician and photographer, was highly commended in the same category.
Dr Adam Hart-Davis, a judge of the awards, photographer, and television presenter, said: "Many of the winning photographs are works of art, and by grabbing your attention they make you look at the world in a new way."
Annabel Ferriman BMJ
For more information see www.visions-of-science.co.uk
